...
首页> 外文期刊>Journal of Clinical Microbiology >Improved primary immunodiagnosis of alveolar echinococcosis in humans by an enzyme-linked immunosorbent assay using the Em2plus antigen.
【24h】

Improved primary immunodiagnosis of alveolar echinococcosis in humans by an enzyme-linked immunosorbent assay using the Em2plus antigen.

机译:通过使用Em2plus抗原的酶联免疫吸附测定,可改善人肺泡衣原虫病的初次免疫诊断。

获取原文
           

摘要

Alveolar echinococcosis (AE) in humans is generally a fatal disease when not diagnosed early enough to provide curative treatment such as radical surgery. Immunodiagnosis for early detection of AE was improved by the isolation of an affinity-purified metacestode Em2 antigen and by the synthesis of recombinant Echinococcus multilocularis antigen II/3-10. Both antigens were individually assessed by enzyme-linked immunosorbent assay (ELISA) and demonstrated high specificities and diagnostic sensitivities, although both missed approximately 4 to 11% of diagnostic cases of AE. To provide an optimal serodiagnostic test, we investigated the two purified antigens by using a test employing a mixture of both purified antigens (designated Em2plus antigen) in one assay. For comparative purposes, crude E. multilocularis and Echinococcus granulosus metacestode antigens were investigated as well. The Em2plus ELISA proved to be the optimal diagnostic test with the highest diagnostic sensitivity, 97%, in serum samples from 140 patients with AE and an overall specificity of 99% for infections due to other Echinococcus and non-Echinococcus parasites. The new test combination (Em2plus ELISA) is suggested for the serodiagnosis of AE in patients and for seroepidemiological surveys.
机译:如果未及早诊断出足以提供根治性手术等根治性治疗,则人类肺泡囊虫病(AE)通常是致命性疾病。通过分离亲和纯化的metacestode Em2抗原和合成重组多球棘球E抗原II / 3-10,可以改善AE早期诊断的免疫诊断。两种抗原均通过酶联免疫吸附测定(ELISA)进行了单独评估,并显示出高特异性和诊断敏感性,尽管两者均遗漏了约AE诊断病例的4%至11%。为了提供最佳的血清诊断测试,我们在一项测定中使用了两种纯化抗原(指定为Em2plus抗原)的混合物,对这两种纯化抗原进行了调查。为了进行比较,还研究了粗叶大肠杆菌和颗粒棘球meta虫的胚乳抗原。在140例AE患者的血清样本中,Em2plus ELISA被证明是最佳的诊断测试方法,具有最高的诊断敏感性,诊断敏感性最高,为97%,对因其他棘球E和非棘球chin虫引起的感染的总体特异性为99%。建议将新的测试组合(Em2plus ELISA)用于患者AE的血清诊断和血清流行病学调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号